|
|   |
Home (13077 companies) > Germany (569 companies) > Pharmaceuticals (13 companies) >
Merck KGaA
| shareholder | country  % source |
|
| subsidiary | country  % source |
|
|
name  items photo compare the prices |
Shop local, ethical and at the best price on Ethishop ! |
|
|
[click on the images below or on help for more information] |
| Delinquency: 4 act(s) of financial or trade delinquency |
| Tax haven, secret bank account, shell companies: operates in 6 offshore financial center(s) |
|
|
Relevance: business & market share |
year | business source |
| 2007 | Merck manufactures 70% of the liquid crystals for flat-faced LCD screens manufactured in the world. | Les Echos |
| 2006 | Third-largest generic drug maker in the world. | Les Echos  |
|
World locations & Manufacturing |
year name | photo position; compensation source |
|
|
year | employees <> | social impact : country source |
| 2005 | 29133 | |  |
| 2003 | -320 | |  |
| 2002 | 34504 | |  |
| 1999 | 32721 | |  |
|
year | financial misdemeanor | sales | income | | | source |
| 2005 |
| 5.9 | 0.66 | |   | billion Eu€ |  |
| 2005 |
Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said. |
| | | |   | | Canadian P.  |
| 2005 |
Its subsidiary, Generics UK, settled with the NHS over claims that it had helped operate a cartel on generic drugs. The company had been accused of working to artificially inflate the price of certain antibiotics and of ulcer medicine Zantac. The company has paid £12m to settle the claims without admission of liability. |
| | | |   | | The Telegr.  |
| 2003 |
| 7.2 | 0.21 | |   | billion Eu€ |  |
| 2002 |
| 7.83 | 0.56 | |   | billion US$ |  |
| 2002 |
market-sharing and price-fixing cartels affecting vitamin products in Europe : 9,24 million euros fine. |
| | | |   | | Commission.  |
| 2002 |
Entente pour fixer le prix de la méthylglucamine entre 1990 et 1999: acquitté pour avoir dénoncé l'entente. |
| | | |   | | Les Echos  |
| 2001 |
| 6.67 | 0.56 | |   | billion US$ |  |
| 2000 |
| 6.35 | 0.2 | |   | billion US$ |  |
| 1999 |
| 5.35 | 0.32 | |   | billion Eu€ |  |
|
|
|
|
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.